Moore Matthew Richard
Officer at ARQT
- Sold, on record
- $105k
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 2, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARQTArcutis Biotherapeutics, Inc.Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARQTPlan not statedMar 2, 2023 2023
Sold 1,610 shares at $15.83 ($25k)
Moore Matthew Richard, Officer
Sold 12.1% of holdings ($211k position)11,690 shares leftFirst sale on recordFiling
- 2 Form 144 notice ARQTNoticeMar 4, 2024 +368 days
Filed to sell 3,468 shares ($39k)
Moore Matthew Richard, Officer
No 10b5-1 planFiling
- 3 Form 4 sale ARQTRoutineMar 4, 2024 same day
Sold 3,468 shares at $11.12 ($39k)
Moore Matthew Richard, SVP and Chief Business Officer
10b5-1 planSold 2.3% of holdings ($1.7M position)146,020 shares leftFollows a Form 144Filing
- 4 Form 144 notice ARQTNoticeMay 2, 2024 +59 days
Filed to sell 4,681 shares ($41k)
Moore Matthew Richard, Officer
No 10b5-1 planFiling
- 5 Form 4 sale ARQTRoutineMay 2, 2024 same day
Sold 4,681 shares at $8.74 ($41k)
Moore Matthew Richard, SVP and Chief Business Officer
10b5-1 planSold 3.1% of holdings ($1.3M position)145,505 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | May 3, 2024 | ARQT | SVP and Chief Business Officer | Form 4 sale | 4,681 | $41k | 3.1% | Routine | SEC |
| May 2, 2024 | May 2, 2024 | ARQT | Officer | Form 144 notice | 4,681 | $41k | Notice | SEC | |
| Mar 4, 2024 | Mar 6, 2024 | ARQT | SVP and Chief Business Officer | Form 4 sale | 3,468 | $39k | 2.3% | Routine | SEC |
| Mar 4, 2024 | Mar 4, 2024 | ARQT | Officer | Form 144 notice | 3,468 | $39k | Notice | SEC | |
| Mar 2, 2023 | Mar 6, 2023 | ARQT | Officer | Form 4 sale | 1,610 | $25k | 12.1% | Plan not stated | SEC |